Overview

Use of Intrathecal Hydromorphone in Elective Cesarean Deliveries

Status:
Completed
Trial end date:
2018-10-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if intrathecal hydromorphone will relieve pain as well as intrathecal morphine after cesarean delivery, with fewer side effects.
Phase:
Early Phase 1
Details
Lead Sponsor:
Grace Shih, MD
Collaborator:
Masimo Corporation
Treatments:
Hydromorphone
Morphine